JP2013532677A5 - - Google Patents

Download PDF

Info

Publication number
JP2013532677A5
JP2013532677A5 JP2013521146A JP2013521146A JP2013532677A5 JP 2013532677 A5 JP2013532677 A5 JP 2013532677A5 JP 2013521146 A JP2013521146 A JP 2013521146A JP 2013521146 A JP2013521146 A JP 2013521146A JP 2013532677 A5 JP2013532677 A5 JP 2013532677A5
Authority
JP
Japan
Prior art keywords
salt
formulation
composition according
pharmaceutically acceptable
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013521146A
Other languages
English (en)
Japanese (ja)
Other versions
JP5860047B2 (ja
JP2013532677A (ja
Filing date
Publication date
Priority claimed from EP10171428A external-priority patent/EP2417982A1/en
Application filed filed Critical
Publication of JP2013532677A publication Critical patent/JP2013532677A/ja
Publication of JP2013532677A5 publication Critical patent/JP2013532677A5/ja
Application granted granted Critical
Publication of JP5860047B2 publication Critical patent/JP5860047B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013521146A 2010-07-30 2011-07-28 Fshの安定化 Active JP5860047B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10171428.5 2010-07-30
EP10171428A EP2417982A1 (en) 2010-07-30 2010-07-30 Stabilization of gonadotropins
PCT/EP2011/062986 WO2012013742A2 (en) 2010-07-30 2011-07-28 Stabilization of fsh

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015245748A Division JP2016102127A (ja) 2010-07-30 2015-12-17 Fshの安定化

Publications (3)

Publication Number Publication Date
JP2013532677A JP2013532677A (ja) 2013-08-19
JP2013532677A5 true JP2013532677A5 (cg-RX-API-DMAC7.html) 2014-09-11
JP5860047B2 JP5860047B2 (ja) 2016-02-16

Family

ID=43216624

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013521146A Active JP5860047B2 (ja) 2010-07-30 2011-07-28 Fshの安定化
JP2015245748A Pending JP2016102127A (ja) 2010-07-30 2015-12-17 Fshの安定化
JP2017212395A Active JP6522711B2 (ja) 2010-07-30 2017-11-02 Fshの安定化

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015245748A Pending JP2016102127A (ja) 2010-07-30 2015-12-17 Fshの安定化
JP2017212395A Active JP6522711B2 (ja) 2010-07-30 2017-11-02 Fshの安定化

Country Status (27)

Country Link
US (3) US8993732B2 (cg-RX-API-DMAC7.html)
EP (3) EP2417982A1 (cg-RX-API-DMAC7.html)
JP (3) JP5860047B2 (cg-RX-API-DMAC7.html)
KR (2) KR101991756B1 (cg-RX-API-DMAC7.html)
CN (2) CN103052398B (cg-RX-API-DMAC7.html)
AR (1) AR082776A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011284702C1 (cg-RX-API-DMAC7.html)
BR (1) BR112013002312B1 (cg-RX-API-DMAC7.html)
CA (1) CA2805864A1 (cg-RX-API-DMAC7.html)
DK (1) DK2598160T3 (cg-RX-API-DMAC7.html)
ES (1) ES2623634T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20170386T1 (cg-RX-API-DMAC7.html)
HU (1) HUE033592T2 (cg-RX-API-DMAC7.html)
IL (2) IL223821A (cg-RX-API-DMAC7.html)
JO (1) JO3229B1 (cg-RX-API-DMAC7.html)
LT (1) LT2598160T (cg-RX-API-DMAC7.html)
MX (2) MX356951B (cg-RX-API-DMAC7.html)
NZ (2) NZ606366A (cg-RX-API-DMAC7.html)
PL (1) PL2598160T3 (cg-RX-API-DMAC7.html)
PT (1) PT2598160T (cg-RX-API-DMAC7.html)
RS (1) RS55772B1 (cg-RX-API-DMAC7.html)
RU (1) RU2574012C2 (cg-RX-API-DMAC7.html)
SA (1) SA114350786B1 (cg-RX-API-DMAC7.html)
SI (1) SI2598160T1 (cg-RX-API-DMAC7.html)
TW (1) TWI439283B (cg-RX-API-DMAC7.html)
WO (1) WO2012013742A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209497B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
MX356383B (es) * 2013-11-12 2018-05-24 Cadila Healthcare Ltd Formulación líquida de gonadotropina estabilizada con polietilenglicol.
CN105727260A (zh) * 2016-02-03 2016-07-06 华侨大学 一种卵泡刺激素的长效制剂
GB201603280D0 (en) 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation
FR3083089A1 (fr) * 2018-06-29 2020-01-03 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
CN111836616B (zh) 2017-12-07 2024-01-16 阿道恰公司 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph 7为7的可注射溶液
BR112020011570A2 (pt) 2017-12-07 2020-12-08 Adocia Solução injetável a um ph 7 compreendendo pelo menos uma insulina basal apresentando um pi entre 5,8 e 8,5 e um co-poliaminoácido contendo cargas de carboxilato e radicais hidrofóbicos
FR3084584B1 (fr) * 2018-08-03 2020-11-06 Adocia Solution injectable a ph 7 comprenant du glucagon humain et un compose amphiphile porteur de radicaux hydrophobes
FR3084586B1 (fr) * 2018-08-03 2020-11-06 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes
JP7425459B2 (ja) * 2019-10-11 2024-01-31 株式会社シノテスト 安定化されたhmgb1含有溶液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA61053C2 (en) 1995-03-21 2003-11-17 Applied Research Systems Stable liquid pharmaceutical compositions, method for its production and delivery form
AU738176B2 (en) * 1996-05-29 2001-09-13 Delsitech Oy Dissolvable oxides for biological applications
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
KR20010083126A (ko) * 1998-07-23 2001-08-31 피터 지. 스트링거 여포자극 호르몬 및 여포자극 호르몬 변이체 제형, 제품및 방법
MXPA06011029A (es) * 2004-04-07 2007-01-25 Ares Trading Sa Formulacion liquida de hormona del crecimiento.
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
SI2249869T1 (sl) * 2008-02-08 2012-01-31 Biogenerix Ag Tekoäśa formulacija fsh
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
CN101614748A (zh) * 2008-06-25 2009-12-30 上海新波生物技术有限公司 促卵泡激素时间分辨免疫荧光分析法及试剂盒
MX2011013898A (es) * 2009-06-22 2012-05-22 Amgen Inc Proteínas replegadas que usan un estado de oxido-reduccion quimicamente controlado.
RU2553375C2 (ru) * 2010-02-12 2015-06-10 Интас Биофармасьютикалс Лимитед Жидкий состав фолликулостимулирующего гормона
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins

Similar Documents

Publication Publication Date Title
JP2013532677A5 (cg-RX-API-DMAC7.html)
RU2012157154A (ru) Стабилизация fsh
JP2014139241A5 (cg-RX-API-DMAC7.html)
RU2015122023A (ru) Стабилизированная композиция пеметрекседа
JP2014218522A5 (cg-RX-API-DMAC7.html)
JP2015525763A5 (cg-RX-API-DMAC7.html)
RU2015132974A (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
JP2014521659A5 (cg-RX-API-DMAC7.html)
AR081015A1 (es) Formulaciones de galactomananos oftalmicas estabilizadas. metodo.
WO2014131739A3 (en) Substituted imidazopyridazines
GB201307548D0 (en) Agrochemical compositions for reducing agrochemical residues
JP2016503058A5 (cg-RX-API-DMAC7.html)
HRP20171824T1 (hr) (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI S DVOJNOM AKTIVNOŠĆU INVERZNIH AGONISTA H1 I ANTAGONISTA 5-HT2A
NZ605860A (en) Use of vitamin c, and chromium-free vitamin k or 2-methyl-1,4-naphthalendione, and compositions thereof for treating a polycystic disease
JP2017509623A5 (cg-RX-API-DMAC7.html)
CL2014000035A1 (es) Composicion en forma de un gel para la preparacion de un producto alimenticio, que comprende agua en una cantidad de 30 a 70% en peso, saborizantes desde 1 a 40%, sal desde 10 a 25% y agentes gelificantes desde 0,15 a 12% que contienen al menos agar y xantano; y proceso para preparar dicha composicion.
JP2018532806A5 (cg-RX-API-DMAC7.html)
WO2014203137A3 (en) Pharmaceutical compositions of tamsulosin or salts thereof
MX2015006331A (es) Composiciones con bajo contenido de sal de sodio y metodos para elaboracion y utilizacion.
AR088918A1 (es) Composiciones antitranspirantes anhidras
HRP20191050T1 (hr) Pripravak protiv virusnog konjunktivitisa koji sadrži jota-karagenan
BR112015014137A2 (pt) unidade sólida com alto teor de fexofenadina e processo para a preparação da mesma
EA201170101A1 (ru) Фармацевтические композиции роувастатина кальция
RU2016137165A (ru) Композиция для применения при лечении боли, связанной с межпозвоночным диском
MX2015007062A (es) Método de producción de sal mineral y productos de sal mineral.